# National Institute of Oncology

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/national-institute-of-oncology/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 61.4 |
| Citations | 335,367 |
| City | Budapest |
| Country | HU |
| Description | National Institute of Oncology is a research organisation in Budapest, HU. OpenAlex records 6,246 works and 335,367 citations for it. 2,066 researchers list it as their most recent affiliation. |
| Homepage | http://www.onkol.hu/en/NIO |
| OpenAlex ID | https://openalex.org/I4210119956 |
| Researchers | 2,066 |
| ROR ID | https://ror.org/02kjgsq44 |
| Type | healthcare |
| Works | 6,246 |

## University papers

Showing 12 of 64.

- [Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer](https://scholariq.org/papers/nivolumab-versus-docetaxel-in-advanced-squamous-cell-non-small-cell-lung-cancer/)
- [The Multimodal Brain Tumor Image Segmentation Benchmark (BRATS)](https://scholariq.org/papers/the-multimodal-brain-tumor-image-segmentation-benchmark-brats/)
- [First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer](https://scholariq.org/papers/first-line-atezolizumab-plus-chemotherapy-in-extensive-stage-small-cell-lung/)
- [Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden](https://scholariq.org/papers/nivolumab-plus-ipilimumab-in-lung-cancer-with-a-high-tumor-mutational-burden/)
- [Interleukin-1 polymorphisms associated with increased risk of gastric cancer](https://scholariq.org/papers/interleukin-1-polymorphisms-associated-with-increased-risk-of-gastric-cancer/)
- [Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma](https://scholariq.org/papers/adjuvant-pembrolizumab-versus-placebo-in-resected-stage-iii-melanoma/)
- [Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up](https://scholariq.org/papers/soft-tissue-and-visceral-sarcomas-esmo-euracan-clinical-practice-guidelines-for/)
- [Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial](https://scholariq.org/papers/cetuximab-plus-chemotherapy-in-patients-with-advanced-non-small-cell-lung-cancer/)
- [Dacomitinib versus gefitinib as first-line treatment for patients with EGFR-mutation-positive non-small-cell lung cancer (ARCHER 1050): a randomised, open-label, phase 3 trial](https://scholariq.org/papers/dacomitinib-versus-gefitinib-as-first-line-treatment-for-patients-with-egfr/)
- [Genome-wide meta-analyses identify multiple loci associated with smoking behavior](https://scholariq.org/papers/genome-wide-meta-analyses-identify-multiple-loci-associated-with-smoking/)
- [A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis](https://scholariq.org/papers/a-placebo-controlled-trial-of-obeticholic-acid-in-primary-biliary-cholangitis/)
- [Colorectal polypectomy and endoscopic mucosal resection (EMR): European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline](https://scholariq.org/papers/colorectal-polypectomy-and-endoscopic-mucosal-resection-emr-european-society-of/)

## University researchers

- [Gábor Székely](https://scholariq.org/researchers/gabor-szekely/)
- [Iwona Ługowska](https://scholariq.org/researchers/iwona-ugowska/)

## University top topics

Showing 8 of 25.

- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)
- [Advanced Radiotherapy Techniques](https://scholariq.org/topics/advanced-radiotherapy-techniques/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)
- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.